Navigation Links
SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria
Date:5/13/2009

troenterology centers in Germany and Austria. Krainer Medtechnik is a perfect partner for SpectraScience as we move our business forward."

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-KSB and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provides the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. In addition, the Company's LUMA(R) Cervical Imaging technology has received FDA approval as an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available today. 

    Contact:
    Spectra
'/>"/>
SOURCE  SpectraScience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related biology technology :

1. SpectraScience CEO Jim Hitchin Featured in Interview With The Wall Street Transcript
2. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis
3. SpectraScience Strengthens Leadership Team With Four Key Hires
4. Jim Dorst Joins SpectraScience as CFO
5. SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors
6. Sinobiopharma Secures Rights to Seven Key Patents
7. Aerovance Secures $38 Million in Equity Financing
8. VIA Pharmaceuticals Secures Financing Up to $10.0 Million
9. Pearl Therapeutics Secures $8 Million in Debt Financing
10. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
11. Sopherion Therapeutics Secures $55 Million in Series C Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Mosaic Company (NYSE: MOS ) plans to ... and financial tables on Tuesday, January 5, 2010, after ... Exchange. Results will be available on Mosaic,s website ... a conference call with presentation slides on Wednesday, January ... will begin at 11:00 a.m. Eastern Standard Time (10:00 ...
(Date:12/15/2009)... Thomson Reuters today announced ... first drug pipeline database to fully integrate detailed ... anticipated new content is being provided to all ... Thomson Pharma will offer drug related ... conferences, and other sources across all therapeutic areas. ...
(Date:12/14/2009)... 14 Vermillion, Inc. (Pink Sheets: ... William C. Wallen, Ph.D. Chief Scientific Officer, ... IDEXX Laboratories, will be joining its board ... plan. ,, "Bill brings more than ... diagnostics and biotechnology," said Gail Page, Vermillion ...
(Date:12/14/2009)... Dec. 14 Boston Scientific Corporation (NYSE: ... public offering of $2 billion aggregate principal amount of ... The public offering consists of $850 million of ... 6.00 percent notes due January 2020 and $300 million ... Scientific plans to use the net proceeds for general ...
Breaking Biology Technology:Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3
... Comprehensive Investor Relations and Media Outreach to ... Transdel,Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP),( ... focused on developing and commercializing non-invasive, topically,administered ... a thirteen-year-old, highly recognized corporate communications,firm based ...
... Research Organization Exceeds Expectations, MEMPHIS, Tenn., ... Research,Organization exclusively focused on oncology, announced today ... projections as the company continues,to experience banner ... ability to consistently exceed client expectations, and ...
... - ("Stem Cell Sciences", "SCS", "the Company"), ... focused on the,commercialisation of stem cells and stem ... agreement with CHDI Foundation, Inc., to support the,standardisation ... lines. CHDI,is a US non-profit organisation pursuing treatments ...
Other Biology Technology:Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group 2Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group 3ACORN CRO Continues Growth in Strong Third Quarter 2Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 2Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 3Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 4
(Date:12/15/2009)... 15, 2009 Economics, environmental impacts, social dynamics, ... influence the overall success of an agroecosystem. Positive ... system, forcing individuals and social groups to continuously ... survive. , Experiential learning theory suggests that ... firsthand experiences. Such lessons are especially valuable for ...
(Date:12/15/2009)... mammoths and ancient American horses may have been ... years longer than previously thought. After plucking ancient ... team of researchers used cutting-edge techniques to uncover ... samples dated to between 7,600 and 10,500 calendar ... one population of these now-extinct mammals endured longer ...
(Date:12/15/2009)... in German . , Leipzig: Species distribution ... future distribution of mammals. This is the finding of ... European mammals. The researchers analysed data on species distribution, ... phylogenetic information of the species. Judging by the large ... mammals seem to adapt fast to changing climatic conditions. ...
Breaking Biology News(10 mins):Experiential learning teaches change and adaptation 2Late-surviving megafauna exposed by ancient DNA in frozen soil 2Late-surviving megafauna exposed by ancient DNA in frozen soil 3Late-surviving megafauna exposed by ancient DNA in frozen soil 4Species distribution models are of only limited value for predicting future mammal distributions 2FRC 3A Senate Votes to Proceed with Abortion Funding Debacle 61883 1FRC 3A Senate Votes to Proceed with Abortion Funding Debacle 61883 2River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 1River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 2River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 3River Blindness 28Onchocerciasis 29 Reduced By Nearly One Third In At Risk Populations In Six Countries 61879 4KINAXO Completes Financing Round to Enhance Biomarker Development 10849 1KINAXO Completes Financing Round to Enhance Biomarker Development 10849 2KINAXO Completes Financing Round to Enhance Biomarker Development 10849 3
... have discovered epigenetic changes (i.e. chemical changes to ... sequence) in individuals with schizophrenia and bipolar disorder. ... research, and this groundbreaking data may be a ... major psychosis. , Dr. Arturas Petronis, senior scientist ...
... as a fuel alternative will worsen pollution in the Gulf ... aquatic life, according to University of British Columbia researcher Simon ... and Chris Kucharik of the University of Wisconsin quantify the ... in a waterway. Their findings will appear in the March ...
... The growth in China,s carbon dioxide (CO2) emissions is ... atmospheric greenhouse gases much more difficult, according to a ... Berkeley, and UC San Diego. , Previous estimates, including ... say the region that includes China will see a ...
Other Biology News:Epigenetic changes discovered in major psychosis 2US rush to produce corn-based ethanol will worsen 'dead zone' in Gulf of Mexico: UBC study 2New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions 2New UC analysis shows alarming increase in expected growth of China's carbon dioxide emissions 3
Fast, sensitive quantitation of Mouse IgM concentration....
Competitors to lower non-specific signal...
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
Anti-ZFP200 Family: Zinc Finger Peptide Sequence: CGKSFNHKTNLNKHER...
Biology Products: